Celldex Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Celldex Therapeutics

07/11/2024 15:09

* Celldex Therapeutics Inc  CLDX.OQ  reported a quarterly
adjusted
loss of 64 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -81 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 67 cents per
share. Wall Street expected results to range from -75 cents
to -58 cents per share.
    * Revenue rose 110.3% to $3.19 million from a year ago;
analysts
expected $828.30 thousand. 
    * Celldex Therapeutics Inc's reported EPS for the quarter
was a
loss of 64 cents​.
    * The company reported a quarterly loss of $42.12 million.
    * Celldex Therapeutics Inc shares had fallen by 18.7% this
quarter and lost 30.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Celldex
Therapeutics Inc is $69.00 
This summary was machine generated from LSEG data November 7 at
03:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.67          -0.64          Beat
 Jun. 30 2024      -0.59          -0.54          Beat
 Mar. 31 2024      -0.69          -0.56          Beat
 Dec. 31 2023      -0.74          -0.83          Missed